Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes

Autor: Fonseca, Vivian, Staels, Bart, Morgan, Jerry D., II, Shentu, Yue, Golm, Gregory T., Johnson-Levonas, Amy O., Kaufman, Keith D., Goldstein, Barry J., Steinberg, Helmut
Zdroj: In Journal of Diabetes and Its Complications March-April 2013 27(2):177-183
Databáze: ScienceDirect
Externí odkaz: